Literature DB >> 26282200

Different roles of GPR120 and GPR40 in the acquisition of malignant properties in pancreatic cancer cells.

Kaori Fukushima1, Eri Yamasaki1, Shuhei Ishii1, Ayaka Tomimatsu1, Kaede Takahashi1, Miku Hirane1, Nobuyuki Fukushima2, Kanya Honoki3, Toshifumi Tsujiuchi4.   

Abstract

Free fatty acids (FFAs) act as extracellular signaling molecules through binding to G-protein-coupled FFA receptors (FFARs). GPR120 and GPR40 are identified as FFARs for medium- and long-chain fatty acids. In the present study, we investigated roles of GPR120 and GPR40 in cellular functions of pancreatic cancer PANC-1 cells, using GPR120 and GPR40 knockdown cells (PANC-sh120 and PANC-sh40 cells respectively). In cell motility assay, PANC-sh120 cells showed the low cell motility, compared with control cells. In contrast, the cell motility of PANC-sh40 cells was significantly higher than that of control cells. Activity levels of matrix metalloproteinases (MMPs) were measured by gelatin zymography. While PANC-sh120 cells indicated the reduced MMP-2 activity, MMP-2 activity in PANC-sh40 cells was significantly higher than that in control cells. On the other hand, no activation of MMP-9 was detected in all cells. In colony assay, the large sized colonies were markedly formed in PANC-sh40 cells. No colony formation was observed in PANC-sh120 cells as well as control cells. These results suggest that distinct effects of GPR120 and GPR40 are involved in the acquisition of malignant property in pancreatic cancer cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell motility; GPR120; GPR40; Invasion; Pancreatic cancer cells

Mesh:

Substances:

Year:  2015        PMID: 26282200     DOI: 10.1016/j.bbrc.2015.08.050

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Serum Free Fatty Acids and G-Coupled Protein Receptors Are Associated With the Prognosis of Epithelial Ovarian Cancer.

Authors:  Lili Zhang; Xiangzhong Zhao; Huijun Chu; Han Zhao; Xiaoying Lai; Jing Li; Teng Lv
Journal:  Front Oncol       Date:  2022-06-17       Impact factor: 5.738

Review 2.  The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.

Authors:  Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

Review 3.  Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

Authors:  M T M van Jaarsveld; J M Houthuijzen; E E Voest
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

4.  GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells.

Authors:  Sang-Kyu Park; Anja Herrnreiter; Sandra L Pfister; Kathryn M Gauthier; Benjamin A Falck; John R Falck; William B Campbell
Journal:  J Biol Chem       Date:  2018-05-18       Impact factor: 5.157

5.  GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.

Authors:  Gabriele Carullo; Sarah Mazzotta; Margarita Vega-Holm; Fernando Iglesias-Guerra; José Manuel Vega-Pérez; Francesca Aiello; Antonella Brizzi
Journal:  J Med Chem       Date:  2021-04-10       Impact factor: 7.446

6.  Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance.

Authors:  Julia M Houthuijzen; Ilse Oosterom; Brian D Hudson; Akira Hirasawa; Laura G M Daenen; Chelsea M McLean; Steffen V F Hansen; Marijn T M van Jaarsveld; Daniel S Peeper; Sahar Jafari Sadatmand; Jeanine M L Roodhart; Chris H A van de Lest; Trond Ulven; Kenji Ishihara; Graeme Milligan; Emile E Voest
Journal:  FASEB J       Date:  2017-02-09       Impact factor: 5.191

7.  GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy.

Authors:  Ji Hye Im; Keon Wook Kang; Sun Young Kim; Yoon Gyoon Kim; Yong Jin An; Sunghyouk Park; Byung Hwa Jeong; Song-Yi Choi; Jin-Sun Lee; Keon Wook Kang
Journal:  J Exp Clin Cancer Res       Date:  2018-11-29

8.  Oleic acid induces migration through a FFAR1/4, EGFR and AKT-dependent pathway in breast cancer cells.

Authors:  Cleofas Marcial-Medina; Alejandra Ordoñez-Moreno; Christian Gonzalez-Reyes; Pedro Cortes-Reynosa; Eduardo Perez Salazar
Journal:  Endocr Connect       Date:  2019-03       Impact factor: 3.335

9.  A Computational Pipeline for the Extraction of Actionable Biological Information From NGS-Phage Display Experiments.

Authors:  Antonios Vekris; Eleftherios Pilalis; Aristotelis Chatziioannou; Klaus G Petry
Journal:  Front Physiol       Date:  2019-09-24       Impact factor: 4.566

Review 10.  Metabolite Sensing GPCRs: Promising Therapeutic Targets for Cancer Treatment?

Authors:  Jesús Cosín-Roger; Dolores Ortiz-Masia; Maria Dolores Barrachina; Sara Calatayud
Journal:  Cells       Date:  2020-10-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.